Introduction
While phenylalanine hydroxylase (PAH) is critically implicated in a range of problems of medical and biological interest, its activity is not fully understood. It is an important metabolic protein responsible for phenylalanine catabolism [1] [2] [3] and over 280 different mutants of the protein have been genetically linked to the well-studied condition phenylketonuria (PKU), 4 a candidate for gene therapy. 5 Two mutants of particular interest are R158Q, which is a common mutant as it comprises 40% of PKU haplotype 4 alleles in Europe, 6 and E280K, which is unusual among PKU mutants as it found on multiple haplotypes. 7 The protein is highly similar to both tryptophan hydroxylase and tyrosine hydroxylase, which perform the same function on their respective amino acids. 1 PAH is found as a highly conserved homodimer or homotetramer of 51.7 kDa subunits, 8, 9 with an iron center in each monomeric unit that binds and cleaves diatomic oxygen. 10, 11 Activated oxygen then participates in one 2 of two competing pathways: the oxidation of phenylalanine to tyrosine, which dominates in wild type PAH, or the formation of hydrogen peroxide, which dominates in the PKUinducing mutants. 12 Despite all the interest in PAH, two critical features in this mechanism of O 2 binding and activation are poorly understood. First, both PKU-inducing mutantions, Arg158Gln and Glu280Lys, occur far from the active site. X-ray crystallography shows that in the wild type these two residues form a salt bridge around 20Å away from the iron center ( Figure 1 ). Why the disruption of this distant interaction affects PAH activity has not been firmly established. The oxygen activating and cleaving activity of PAH is not well understood structurally. In the Siegbahn mechanism, the metal has an additional water ligand and oxygen binds to the metal before the cofactor. According to the Solomon mechanism a change in orientation of the cofactor could explain the preferential H 2 O 2 forming activity of the mutant.
Our study starts with structures implicated in a prominent mechanism put forward by the laboratory of Prof. Solomon based on spectroscopic data, 12 which posits solid initial hypotheses on our two mechanistic questions but lacks sufficient atomistic evidence to support them. This mechanism hypothesizes that O 2 binds first to BH 4 and then to the metal in the natural, tyrosine forming pathway. It then conjectures that the cofactor is positioned improperly in the active site of the mutants, so that O 2 instead binds just to BH 4 and forms H 2 O 2 in the pathological pathway. The Solomon study also notes the proximity of Arg158 to two loops around the active site identified in a previous study: one comprising residues 131-155 and another comprising residues 247-251 which forms some hydrogen-bonding contacts with the cofactor. 9, 12 However, neither of these contacts fully explain the coupling between the mutant residues and the cofactor for a number of reasons. First, they hinge just on the simple proximity of Arg158 rather than specific interactions. Second, they are based on a single crystal structure of the PAH wild type and contain no information about the mutant state. Finally, as they are based on a single structure they consequentially ignore any dynamic aspects of long-range coupling. These gaps in knowledge necessitate an all-atom investigation of PAH O 2 binding activity.
We also consider structures from a potentially problematic mechanism suggested by the laboratory of Prof. Seigbahn based on DFT studies of small models of the PAH active site. 17 For the O 2 binding step of interest to us the model this mechanism utilized lacks the necessary presence of the phenylalanine substrate and has an inappropriate additional water ligand bound to the iron center rendering it inconsistent with previous kinetic and spectroscopic findings. 12 It thus corresponds more closely to an inactive form of PAH. Our consideration of this mechanism therefore acts as a negative control to see if any dynamic behavior we identify is truly unique to the O 2 binding step or a general property of the protein.
In this study, we performed extensive mixed quantum-classical dynamics simulations on the whole protein and its two pathogenic mutants at full atomistic resolution with QM/DMD, a rapid sampling method for metalloproteins (described fully in the methods section). The 
Theoretical Methods
A total of 7 replicates for each of the Siegbahn systems and 10 replicates for each of the Solomon systems were run. Simulations were run for 40 to 80 ns. Details about the preparation of each system and the results of the undiscussed systems can be found in the supplementary information.
The established QM/DMD method was used for these simulations. 18 This is a technique for sampling metalloprotein conformations which uses discrete molecular dynamics (DMD) 19 to describe the protein and quantum mechanical (QM) electronic structure calculations necessary to model the metal and its environs. Both methods treat an overlapping region, consisting of species participating in important, non-covalent interactions near the metal, to mitigate discontinuity errors. QM/DMD has a strong record and our group has used it to successfully explain a range of metalloenzyme behavior. These include metal- 
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All QM calculations in this study were performed at the DFT level of theory with Turbomole (version 6.6). 28 The pure meta-GGA TPSS functional 29 with the D3 dispersion correction 30 was used. The metal was treated with the triple-zeta basis set def2-TZVPP and all other atoms with the double-zeta def2-SVP basis set. 31 While the small basis set may result in some degree of basis set superposition error, the large size of our QM regions have precluded the use of larger basis sets. Furthermore, the level of theory employed without correction has proven effective in our cited past studies including for quantitative free energy comparisons. Finally, the Conductor-like Screen Model (COSMO) with a constant dielectric of 4 was applied to approximate the screening and solvation effects in the relatively buried active sites of the systems. 32 All DMD simulations in this study were performed for 10,000 steps per iteration (0.5 ns).
Convergence of the QM/DMD simulations was achieved according to a series of metrics.
These consist of the full protein all-atom RMSD (calculated with respect to all atoms in our models), active site all-atom RMSD (calculated for just the atoms in our QM region) and the DMD energy and QM energy. The RMSD values were calculated with the initial protein equilibrated for one QM/DMD iteration as the reference structure. The full protein all-atom RMSD trajectories of each system are included in this text as an example (Figure 2 ), while plots of the other three standards can be found in the supporting information.
Results and Discussion
The QM/DMD simulations show the Seigbahn system to be conformationally stiff, with little difference between the wild type and mutant structures. The full protein RMSDs of the PAH variants indicate well converged trajectories: 1.89 ± 0.19Å for the WT versus Additional confirmation for the discovered dynamic coupling was found through a dedicated coupled-dynamics method developed by the Dokholyan group. The method calculates Histogram of the BH 4 to Tyr377 minimum distance for the wild type (white) and the R158Q mutant (dark gray). The height of each bar represents the percentage of iterations across all replicates with an angle in that 0.5Å threshold. The color visible above a bar with the blended medium gray represents the form of the protein in excess for that threshold. This chart shows that the frequency of a hydrogen-bonding interaction between these two species, which occurs around 2 to 4 angstroms, is much higher in the wild type.
correlated motions between residues and constructs pathways with Dijkstra's algorithm. It was used to great effect to study allosteric behavior in pathogenic cystic fibrosis regulator ion channel mutants. 33, 34 A simplified protocol was applied to the lowest energy structure of each of the studied systems (results for the Siegbahn structures can be found in the supporting information). In the Solomon wild type, the method finds a strong coupled-dynamics pathway which connects the site of mutation to Tyr377 through the same series of loops identified in QM/DMD simulations ( Figure 6 ). This coupled-dynamics pathway is diverted in the R158Q mutant, consistent with its looser control of the position of Tyr377.
The identified coupling between the cofactor, Tyr377, is an unique, directing interaction necessary to understand the BH 4 orientational preferences. The cofactor forms other hydrogen-bonding contacts, namely with the loop of residues 147-151. These are the most obvious interactions, as they are present in the original crystal structure (PDB: 1KW0) while the hydroxyl oxygen of the cofactor and Tyr377 are 6.39Å apart. However, the contacts backbone carbonyls all form hydrogen bonds with the cofactor (Figure 7) . As with Tyr377, we measured the distance between the atoms in these groups that can hydrogen bond and their nearest partner on the cofactor for all iterations of our simulations. Unlike Tyr377, the average distance of each of these contacts varies little between the wild type and mutant, at just 3.12 ± 1.48Å (WT) vs 2.79 ± 1.10Å (R158Q) for Ser151, 3.24 ± 1.09Å (WT) vs 3.65 ± 1.26Å (R158Q) for Leu132, and 3.26 ± 1.09Å (WT) vs 2.79 ± 1.10Å (R158Q)
for Gly130, compared to a significant 3.87 ± 1.48Å (WT) vs 5.23 ± 1.23Å (R158Q) for Tyr377. These differences suggest that the angular preferences of the cofactor correlate with its interaction with Tyr377, but not with the nearly constant hydrogen-bonds between BH 4 and the 147-151 loop. Ultimately, it is the subtle, shifting interaction that proves most important in understanding PAH activity at an atomic level. 
Conclusion
In summary, QM/DMD simulations assessed whether the Solomon mechanism for the catabolism of phenylalanine by PAH could explain the sharp drop in healthy activity in the case of two disease-inducing mutants. The Solomon structure simulations capture the predicted role of both the cofactor and site of mutation on PAH activity through an dynamic, long-range pathway of communication. The results are reinforced by negative-control simulations of structures implicated in the Seigbahn mechanism and coupled-dynamics analysis. Together, they show that the orientation of BH 4 directs PAH to follow one of two pathways and is modified in the mutants by way of an interaction with Tyr377. Our discovery that a dynamic interaction correlates with PAH activity, especially in contrast to other hydrogen-bonding contacts with the cofactor that do not, demonstrates the importance of considering proteins as flexible objects comprised of an ensemble of important structures. Given the critical role of PAH and related amino acid hydroxylases in bodily amino acid regulation and their implications in disease we hope our findings and perspective will assist future biological and medical research.
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